Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Many factors have been shown to promote myelination, but few have been shown to be inhibitory. Here, we show that polysialylated-neural cell adhesion molecule (PSA-NCAM) can negatively regulate myelin formation. During development, PSA-NCAM is first expressed on all growing fibers; then, axonal expression is down-regulated and myelin deposition occurs only on PSA-NCAM-negative axons. Similarly, in cocultures of oligodendrocytes and neurons, PSA-NCAM expression on axons is initially high, but decreases as myelination proceeds. Importantly, if expression of PSA-NCAM is prematurely decreased in cultures, by either antibody-mediated internalization or enzymatic removal of the PSA moieties with endoneuraminidase N (endo-N), myelination increases 4- to 5-fold. In the optic nerve, premature cleavage of PSA moieties by intravitreous injection of endo-N also induces a transient increase in the number of myelinated internodes, but does not interfere with the onset of myelination. Previously, we showed that axonal electrical activity strongly induced myelination, which could be prevented by tetrodotoxin (TTX), an action potential blocker. Interestingly, removal of PSA moieties does not reverse the inhibition of myelination by TTX. Together, this suggests that myelination is tightly controlled by both positive (electrical activity) and negative (PSA-NCAM expression) regulatory signals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ncam1 (Fig. 6b),a protein that negatively regulates myelination36.”
From Cell type- and brain region-resolved mouse brain proteome (2015) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
Bottenstein, J. E., & Sato, G. H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.514 · Cited by 2,276
Notch Receptor Activation Inhibits Oligodendrocyte Differentiation
Wang, S., Sdrulla, A. D., diSibio, G., Bush, G., Nofziger, D., Hicks, C., Weinmaster, G., & Barres, B. A. (1998) · Neuron · doi:10.1016/s0896-6273(00)80515-2 · Cited by 705
Induction of myelination in the central nervous system by electrical activity
Demerens, C., Stankoff, B., Logak, M., Anglade, P., Allinquant, B., Couraud, F., Zalc, B., & Lubetzki, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9887 · Cited by 678
Self-citationMultiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions
Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R., & Cho, E. ‐. (1993) · Annals of Neurology · doi:10.1002/ana.410330203 · Cited by 574
Polysialic acid in the vertebrate nervous system: a promoter of plasticity in cell-cell interactions
Rutishauser, U. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10041-2 · Cited by 538
Seki, T., & Arai, Y. (1993) · Neuroscience Research · doi:10.1016/0168-0102(93)90111-3 · Cited by 397
CAM-FGF Receptor Interactions: A Model for Axonal Growth
Doherty, P., & Walsh, F. S. (1996) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1996.0049 · Cited by 379
Polysialic acid in the vertebrate nervous system: a promoter of plasticity in cell-cell interactions
Rutishauser, U. S. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10041-2 · Cited by 325
Polysialic acid as a regulator of intramuscular nerve branching during embryonic development
Landmesser, L., Dahm, L., Tang, J., & Rutishauser, U. (1990) · Neuron · doi:10.1016/0896-6273(90)90193-j · Cited by 316
Doherty, P., Cohen, J., & Walsh, F. S. (1990) · Neuron · doi:10.1016/0896-6273(90)90310-c · Cited by 298
Cited by
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Myelination and support of axonal integrity by glia
Nave, K.-A. (2010) · Nature · doi:10.1038/nature09614 · Cited by 1,062
Myelination of the Nervous System: Mechanisms and Functions
Nave, K.-A., & Werner, H. B. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013101 · Cited by 983
Oligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933
“Only when this form of NCAM is downregulated, as it is in electrically active neurons [91, 97], myelination can proceed [32].”
BackgroundCell type- and brain region-resolved mouse brain proteome
Sharma, K., Schmitt, S., Bergner, C. G., Tyanova, S., Kannaiyan, N., Manrique-Hoyos, N., Kongi, K., Cantuti, L., Hanisch, U.-K., Philips, M.-A., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4160 · Cited by 785
Kuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
Why does remyelination fail in multiple sclerosis?
Franklin, R. J. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn917 · Cited by 837
“The expression of the adhesion molecule PSA-NCAM by axons can also inhibit differentiatio”
BackgroundThe Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
“…to remyelination due to intrinsic axolemmal changes, possibly including expression of inhibitory cell surface molecules such as polysialylated-neural cell adhesion molecule (Charles et al., 2000), changes in membrane caliber, neurofilament fragmentation, or energy failure (Dutta et al., 2006).”
BackgroundSchnaar, R. L., Gerardy-Schahn, R., & Hildebrandt, H. (2014) · Physiological Reviews · doi:10.1152/physrev.00033.2013 · Cited by 745
“The presence of polySia on axons hampers myelin formation in vitro (74), and chronically demyelinated axons in multiple sclerosis lesions reexpress polySia (75).”
BackgroundMyelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
“A number of such inhibitory molecules such as polysialylated neural cell adhesion molecule (PSA-NCAM) on immature neurons (112), junctional adhesion molecule 2 (JAM2) on the somatodendritic compartment (513), limbic system-associated membrane protein (Lsamp) on neurons of the limbic system (565), and class 3 semaphori…”
BackgroundAxon-Glial Signaling and the Glial Support of Axon Function
Nave, K.-A., & Trapp, B. D. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094309 · Cited by 658
“F or p er so na l u se o nl y. presence of PSA-NCAM and L1 on the axon (Charles et al. 2000).”
BackgroundRegulation of oligodendrocyte differentiation and myelination
Emery, B. (2010) · Science · doi:10.1126/science.1190927 · Cited by 653
Remyelination in multiple sclerosis
Piaton, G., Williams, A., Seilhean, D., & Lubetzki, C. (2009) · Progress in Brain Research · doi:10.1016/s0079-6123(09)17530-1 · Cited by 441
Self-citationPSA-NCAM in mammalian structural plasticity and neurogenesis
Bonfanti, L. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.08.003 · Cited by 438
Edg8/S1P5: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival
Jaillard, C., Harrison, S., Stankoff, B., Aigrot, M. S., Calver, A. R., Duddy, G., Walsh, F. S., Pangalos, M. N., Arimura, N., Kaibuchi, K., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4645-04.2005 · Cited by 338
Self-citationKaplan, M. R., Cho, M.-H., Ullian, E. M., Isom, L. L., Levinson, S. R., & Barres, B. A. (2001) · Neuron · doi:10.1016/s0896-6273(01)00266-5 · Cited by 304
“…along its axons prior to glial contact, defining been shown to block myelin ensheathment (Meyer- Coculture of Neurons and GliaFranke et al., 1999; Charles et al., 2000), but it remains Cultures of P8 optic nerve glial cells were prepared as describedcontroversial whether high levels of…”
BackgroundCharles, P., Tait, S., Faivre-Sarrailh, C., Barbin, G., Gunn-Moore, F., Denisenko-Nehrbass, N., Guennoc, A.-M., Girault, J.-A., Brophy, P. J., & Lubetzki, C. (2002) · Current Biology · doi:10.1016/s0960-9822(01)00680-7 · Cited by 297
Self-citationMoreau-Fauvarque, C., Kumanogoh, A., Camand, E., Jaillard, C., Barbin, G., Boquet, I., Love, C., Jones, E. Y., Kikutani, H., Lubetzki, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09229.2003 · Cited by 293
“Cultures were performed as described (Demerens et al., 1996; Charles et al., 2000) either on poly-L-lysine-coated 14 mm glass coverslips (OSI, Maurepas, France) or directly on poly-L-lysine-coated 24-well plastic plates.”
Self-citationCharles, P. (2002) · Brain · doi:10.1093/brain/awf216 · Cited by 288
“It was therefore proposed that removal of PSANCAM from the axonal surface is necessary to render the axon permissive for myelination (Charles et al., 2000).”
BackgroundInfluentialSelf-citationSignals to promote myelin formation and repair
Taveggia, C., Feltri, M. L., & Wrabetz, L. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.37 · Cited by 286
Remyelination therapies: a new direction and challenge in multiple sclerosis
Plemel, J. R., Liu, W.-Q., & Yong, V. W. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.115 · Cited by 281
Stankoff, B., Aigrot, M.-S., Noël, F., Wattilliaux, A., Zalc, B., & Lubetzki, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09221.2002 · Cited by 262
“…of inhibitory signals, one of them being the downregulation of the polysialylated neural cell adhesion molecule from the axonal surface (Charles et al., 2000), and the induction of positive signals, some of which are mediated by the neuronal electrical activity (Demerens et al., 1996).”
BackgroundMethodInfluentialSelf-citationInhibition of Myelin Membrane Sheath Formation by Oligodendrocyte-derived Exosome-like Vesicles
Bakhti, M., Winter, C., & Simons, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190009 · Cited by 253
Mechanisms regulating the development of oligodendrocytes and central nervous system myelin
Mitew, S., Hay, C. M., Peckham, H., Xiao, J., Koenning, M., & Emery, B. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.029 · Cited by 251
Cell migration in the normal and pathological postnatal mammalian brain
Cayre, M., Canoll, P., & Goldman, J. E. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.001 · Cited by 234
“, 2004a) but PSA needs to be downregulated before efficient remyelination occurs (Charles et al., 2000; Fewou et al., 2007).”
BackgroundInflammation stimulates remyelination in areas of chronic demyelination
Foote, A. K. (2005) · Brain · doi:10.1093/brain/awh417 · Cited by 230
“Investigation is needed of whether inflammation also induces changes on the axon that would facilitate myelination, such as removal of the polysialylated neural cell adhesion molecule shown to inhibit myelination (Charles et al., 2000).”
BackgroundThe geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation
Rosenberg, S. S., Kelland, E. E., Tokar, E., De La Torre, A. R., & Chan, J. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805640105 · Cited by 226
Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis
Simons, M., & Trajkovic, K. (2006) · Journal of Cell Science · doi:10.1242/jcs.03242 · Cited by 218
“The removal of some of these proteins, such as the polysialated adhesion molecule NCAM, is essential and allows the myelination process to proceed (Charles et al., 2000).”
BackgroundIndividual axons regulate the myelinating potential of single oligodendrocytes in vivo
Almeida, R. G., Czopka, T., ffrench-Constant, C., & Lyons, D. A. (2011) · Development · doi:10.1242/dev.071001 · Cited by 214
Glia Disease and Repair—Remyelination
Franklin, R. J. M., & Goldman, S. A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020594 · Cited by 208
“The demyelinated axon itself has been implicated in remyelination failure, because demyelinated axons have been shown to express the adhesion molecule PSA-NCAM (Charles et al. 2002), which inhibits myelination in cell culture (Charles et al. 2000).”
BackgroundOligodendrocyte Fate after Spinal Cord Injury
Almad, A., Sahinkaya, F. R., & McTigue, D. M. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0033-5 · Cited by 208
Angata, K. (2003) · Biochimie · doi:10.1016/s0300-9084(03)00051-8 · Cited by 205
Astrocytes in glaucomatous optic neuropathy
Hernandez, M. R., Miao, H., & Lukas, T. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)01125-4 · Cited by 193
“All data points represent mean 7SD of three independen with permission). degenerations (Charles et al., 2000).”
Self-citationType III neuregulin‐1 promotes oligodendrocyte myelination
Taveggia, C., Thaker, P., Petrylak, A., Caporaso, G. L., Toews, A., Falls, D. L., Einheber, S., & Salzer, J. L. (2008) · Glia · doi:10.1002/glia.20612 · Cited by 193
“Signals that inhibit myelination have been described (Charles et al., 2000; Wang et al., 1998).”
BackgroundBiological function of sialic acid and sialylation in human health and disease
Zhu, W., Zhou, Y., Guo, L., & Feng, S. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02180-3 · Cited by 177
“However, long-term over-expression of PolySia may impede myelination or remyelination [125, 129 – 131], as it acts as a ‘ repulsive strut ’ on unmyelinated or demyelinated axons.”
BackgroundEnhancing remyelination in disease--can we wrap it up?
Kotter, M. R., Stadelmann, C., & Hartung, H.-P. (2011) · Brain · doi:10.1093/brain/awr014 · Cited by 181
“…derive from studies demonstrating that antibody-mediated masking or removal of PSA sites by treatment with endoneuraminidase N, an enzyme that specifically hydrolyses PSA, can promote the formation of myelinating internodes in mouse neuron–oligodendrocyte co-cultures (Charles et al., 2000).”
BackgroundMultiple sclerosis: Prospects and promise
Hauser, S. L., Chan, J. R., & Oksenberg, J. R. (2013) · Annals of Neurology · doi:10.1002/ana.24009 · Cited by 179
Oligodendrogenesis in the normal and pathological central nervous system
El Waly, B., Macchi, M., Cayre, M., & Durbec, P. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00145 · Cited by 179
Contribution of the Neural Cell Adhesion Molecule to Neuronal and Synaptic Plasticity
Kiss, J. Z., & Müller, D. (2001) · Reviews in the Neurosciences · doi:10.1515/revneuro.2001.12.4.297 · Cited by 167
On the biogenesis of myelin membranes: Sorting, trafficking and cell polarity
Baron, W., & Hoekstra, D. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.10.085 · Cited by 162
“Interestingly, other axonal proteins such as PSA-NCAM and LINGO-1 that are developmentally downregulated may delay the rate of myelination [78,79], thus reflecting the tight balance of regulation of myelination by axonal protein expression per se.”
BackgroundThe translational biology of remyelination: past, present, and future
Franklin, R. J. M., & Gallo, V. (2014) · Glia · doi:10.1002/glia.22622 · Cited by 162
“PSA-NCAM expression in axons is drastically downregulated during myelination and its loss from the axonal surface coincides with initiation of myelination (Charles et al., 2000).”
BackgroundDemyelination in multiple sclerosis
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52001-2.00004-2 · Cited by 153
“During development PSA-NCAMhas been shown, both in vitro and in vivo, to regulate myelination negatively, and removing it from the axonal surface is necessary to initiate the process of myelination (Charles et al., 2000).”
Self-citationIntrinsic and adaptive myelination—A sequential mechanism for smart wiring in the brain
Bechler, M. E., Swire, M., & ffrench‐Constant, C. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22518 · Cited by 152
“Here, PSA-NCAM expressed on the surface of non-remyelinated axons in multiple sclerosis lesions prevented myelination in culture (Charles et al., 2000; Charles, 2002).”
Yang, H.-J., Vainshtein, A., Maik-Rachline, G., & Peles, E. (2016) · Nature Communications · doi:10.1038/ncomms10884 · Cited by 150
Papastefanaki, F., Chen, J., Lavdas, A. A., Thomaidou, D., Schachner, M., & Matsas, R. (2007) · Brain · doi:10.1093/brain/awm155 · Cited by 147
Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination
Podbielska, M., Banik, N., Kurowska, E., & Hogan, E. (2013) · Brain Sciences · doi:10.3390/brainsci3031282 · Cited by 146
“Conversely, cleavage of PSA from NCAM in co-cultures of oligodendrocytes and neurons substantially increases myelin formation [110] indicating that this posttranslational protein modification is important for restoring”
BackgroundPedre, X., Mastronardi, F., Bruck, W., López-Rodas, G., Kuhlmann, T., & Casaccia, P. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4507-10.2011 · Cited by 145
Larsen, P. H., DaSilva, A. G., Conant, K., & Yong, V. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1880-05.2006 · Cited by 138
“For example, changes in polysialylated-neural cell-adhesion molecules (PSA-NCAM) are linked to the initiation of myelination (Charles et al., 2000).”
Revisiting the Function of PSA-NCAM in the Nervous System
Cremer, H., & Durbec, P. (2001) · Molecular Neurobiology · doi:10.1385/mn:24:1-3:053 · Cited by 152
Inhibition of CNS Remyelination by the Presence of Semaphorin 3A
Syed, Y. A., Hand, E., Möbius, W., Zhao, C., Hofer, M., Nave, K. A., & Kotter, M. R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4930-10.2011 · Cited by 134
The complex world of oligodendroglial differentiation inhibitors
Kremer, D., Aktas, O., Hartung, H., & Küry, P. (2011) · Annals of Neurology · doi:10.1002/ana.22415 · Cited by 131
Remyelinating strategies for the treatment of multiple sclerosis
Stangel, M., & Hartung, H.-P. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00105-3 · Cited by 126
Angata, K., Huckaby, V., Ranscht, B., Terskikh, A., Marth, J. D., & Fukuda, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00205-07 · Cited by 122
“When PSA-NCAM is absent, myelination is disorganized in vivo and accelerated in vitro (9, 10), as we observed aberrantly increased glial differentiation of neurosphere cells from both double mutants and NCAM single mutant mice.”
BackgroundEvidence for Myelin Sheath Remodeling in the CNS Revealed by In Vivo Imaging
Auer, F., Vagionitis, S., & Czopka, T. (2018) · Current Biology · doi:10.1016/j.cub.2018.01.017 · Cited by 120
Oligodendrocytes in a Nutshell
Michalski, J.-P., & Kothary, R. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00340 · Cited by 118
“Glutamate fits nicely with a paradigm for circuit activation wherein stimulation and axon firing, resulting in neurotransmitter release, signals to the OL that the axon is ready to myelinate (Charles et al., 2000; Wake et al., 2011).”
BackgroundMyelin regulatory factor drives remyelination in multiple sclerosis
Duncan, G. J., Plemel, J. R., Assinck, P., Manesh, S. B., Muir, F. G. W., Hirata, R., Berson, M., Liu, J., Wegner, M., Emery, B., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1741-7 · Cited by 114
“In addition, inhibitory substrates on axons such as polysialylated-neural cell adhesion molecule [8], myelin debris [33, 48], extracellular molecules like fibronectin [57], and chondroitin sulfate proteoglycans (CSPGs) [30] may inhibit remyelination.”
BackgroundFrom demyelination to remyelination: The road toward therapies for spinal cord injury
Papastefanaki, F., & Matsas, R. (2015) · Glia · doi:10.1002/glia.22809 · Cited by 113
“…enhanced survival and migration as well as a better capacity to mix with astrocytes without impairment of their myelinating ability (Lavdas et al., 2006; Luo et al., 2011; Papastefanaki et al., 2007) despite the inhibitory role of axonally expressed PSA-NCAM on myelination (Charles et al., 2000).”
BackgroundAchievements and obstacles of remyelinating therapies in multiple sclerosis
Stangel, M., Kuhlmann, T., Matthews, P. M., & Kilpatrick, T. J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.139 · Cited by 118
The Molecular Basis for Remyelination Failure in Multiple Sclerosis
Gruchot, J., Weyers, V., Göttle, P., Förster, M., Hartung, H.-P., Küry, P., & Kremer, D. (2019) · Cells · doi:10.3390/cells8080825 · Cited by 109
“In addition, there also seems to be a relative overexpression of various inhibitors of OPC differentiation, including, inter alia, extracellular axonal ligands, such as PSA-NCAM [30], LINGO-1 [31], Jagged [32] and Galectin-4 [33], which were all shown to directly block OPC differentiation.”
BackgroundMiller, R. H., & Mi, S. (2007) · Nature Neuroscience · doi:10.1038/nn1995 · Cited by 125
Oltmann-Norden, I., Galuska, S. P., Hildebrandt, H., Geyer, R., Gerardy-Schahn, R., Geyer, H., & Mühlenhoff, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708463200 · Cited by 107
Plemel, J. R., Manesh, S. B., Sparling, J. S., & Tetzlaff, W. (2013) · Glia · doi:10.1002/glia.22535 · Cited by 107
“, 2004, 2005), and PSA-NCAM (Charles et al., 2000; Fewou et al., 2007) can inhibit OPC development.”
BackgroundPolysialic Acid: Versatile Modification of NCAM, SynCAM 1 and Neuropilin-2
Mühlenhoff, M., Rollenhagen, M., Werneburg, S., Gerardy‐Schahn, R., & Hildebrandt, H. (2013) · Neurochemical Research · doi:10.1007/s11064-013-0979-2 · Cited by 106
“Moreover, developmental myelination is negatively regulated by the presence of polySia on axons and re-expression of polySia as detected on chronically demyelinated axons in multiple sclerosis could act as an inhibitor of remyelination [31, 32].”
BackgroundAxonal selection and myelin sheath generation in the central nervous system
Simons, M., & Lyons, D. A. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.04.007 · Cited by 130
Axon‐oligodendrocyte interactions during developmental myelination, demyelination and repair
Piaton, G., Gould, R. M., & Lubetzki, C. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06831.x · Cited by 102
“In myelinating co-cultures, PSA-NCAM disappearance from the axonal surface is coincident with initiation of myelin deposition, and suppression of sialylated determinants increases myelination (Charles et al. 2000).”
BackgroundSelf-citationNpc1 Acting in Neurons and Glia Is Essential for the Formation and Maintenance of CNS Myelin
Yu, T., & Lieberman, A. P. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003462 · Cited by 102
“We first examined proteins that mediate signaling between axons and oligodendrocyte lineage cells including PSANCAM [28], Lingo1 [29] and Jagged1 [30], and found no differences between Npc1flox/2, Syn1-Cre+ mutants and controls at P16 (Figure S2A).”
BackgroundBiphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases
Maki, T., Hayakawa, K., Pham, L.-D. D., Xing, C., Lo, E. H., & Arai, K. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312030004 · Cited by 101
“In addition, other axonal ligands polysialylated-neural cell adhesion molecule (PSA-NCAM) [70] or LINGO-1 [71] are also known as inhibitory molecules for myelination.”
BackgroundOligodendrocytes: Myelination, Plasticity, and Axonal Support
Simons, M., Gibson, E. M., & Nave, K. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041359 · Cited by 117
Vlkolinský, R., Cairns, N., Fountoulakis, M., & Lubec, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00218-4 · Cited by 95
Axonal signals in central nervous system myelination, demyelination and remyelination
Coman, I., Barbin, G., Charles, P., Zalc, B., & Lubetzki, C. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.029 · Cited by 111
“Furthermore, suppression of sialylated determinants by specific antibodies, or enzymatic cleavage, increases myelination [15].”
BackgroundSelf-citationPolysialic acid in brain development and synaptic plasticity
Hildebrandt, H., & Dityatev, A. (2013) · Topics in current chemistry · doi:10.1007/128_2013_446 · Cited by 94
“In this in vitro system, removal of polySia enhanced myelin formation, but, in contrast to the studies on OPCs discussed above, the negative regulation of myelination was attributed to the presence of polySia on axons, thought to prevent attachment of the myelin-forming oligodendrocyte processes [177].”
Down-regulation of Polysialic Acid Is Required for Efficient Myelin Formation
Fewou, S. N., Ramakrishnan, H., Büssow, H., Gieselmann, V., & Eckhardt, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610797200 · Cited by 93
The logistics of myelin biogenesis in the central nervous system
Snaidero, N., & Simons, M. (2017) · Glia · doi:10.1002/glia.23116 · Cited by 91
“Inhibitory myelin guidance molecules such as PSANCAM on immature neurons (Charles et al. 2000), JAM2 on the somatodendritic compartment (Redmond et al.”
BackgroundWeinmann, O., Schnell, L., Ghosh, A., Montani, L., Wießner, C., Wannier, T., Rouiller, E. M., Mir, A. K., & Schwab, M. E. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.03.007 · Cited by 89
“…of antibodies binding to cell surface constituents is a very frequent reaction of cells in vitro and vivo; typically, the antibodies are internalized as a complex together with their binding partners (Charles et al., 2000; Qian et al., 1997; Tolbert and Lameh, 1998; Friedman et al., 2005).”
BackgroundChamberlain, K. A., Nanescu, S. E., Psachoulia, K., & Huang, J. K. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.010 · Cited by 87
“While OPCs continue to be recruited to demyelinated regions in approximately 70% of lesions (Chang et al., 2002; Lucchinetti et al., 1999), their differentiation into re-myelinating cells is halted (Back et al., 2005; Charles et al., 2002, 2000; Fancy et al., 2010; Mi et al., 2005).”
BackgroundMothe, A. J., & Tator, C. H. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.024 · Cited by 95
Mehanna, A., Jakovcevski, I., Acar, A., Xiao, M., Loers, G., Rougon, G., Irintchev, A., & Schachner, M. (2010) · Molecular Therapy · doi:10.1038/mt.2009.235 · Cited by 84
Self-citationGhosh, M., Tuesta, L. M., Puentes, R., Patel, S. P., Melendez, K., Maarouf, A. E., Rutishauser, U. S., & Pearse, D. D. (2012) · Glia · doi:10.1002/glia.22330 · Cited by 87
“…expression on SCs does not alter their ability to myelinate axons of dorsal root ganglion neurons (Lavdas et al., 2006; Papastefanaki et al., 2007), although other studies have reported that PSA expression negatively correlates with CNS myelination (Charles et al., 2000; Koutsoudaki et al., 2010).”
BackgroundWhy Is N-Glycolylneuraminic Acid Rare in the Vertebrate Brain?
Davies, L. R. L., & Varki, A. (2013) · Topics in Current Chemistry · doi:10.1007/128_2013_419 · Cited by 80
“Later in development, downregulation of polySia has been found to be necessary for myelination of axons [63, 64].”
BackgroundExtracellular cues influencing oligodendrocyte differentiation and (re)myelination
Wheeler, N. A., & Fuss, B. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.03.019 · Cited by 92
“Notably, downregulation of PSA-NCAM from OLG surfaces was found to be critical for efficient myelination and myelin maintenance (Charles et al., 2000; Fewou et al., 2007).”
Loss of Branched O-Mannosyl Glycans in Astrocytes Accelerates Remyelination
Kanekiyo, K., Inamori, K.-I., Kitazume, S., Sato, K., Maeda, J., Higuchi, M., Kizuka, Y., Korekane, H., Matsuo, I., Honke, K., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3137-12.2013 · Cited by 78
“For example, a brain-specific polysialic acid moiety on neural cell adhesion molecule negatively regulates myelin formation (Charles et al., 2000).”
BackgroundRegulation of oligodendrocyte precursor migration during development, in adulthood and in pathology
de Castro, F., Bribián, A., & Ortega, M. C. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1365-6 · Cited by 93
“Axons have been implicated in the final stage of oligodendrocyte maturation [59, 160, 161].”
BackgroundJakovčevski, I., Mo, Z., & Zečević, N. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.044 · Cited by 88
“Of special interest is that PSA-NCAM has been implicated as an inhibitor of primary myelination in mice (Charles et al., 2000).”
BackgroundLavdas, A. A., Franceschini, I., Dubois-Dalcq, M., & Matsas, R. (2006) · Glia · doi:10.1002/glia.20340 · Cited by 78
“PSA on axons is downregulated during myelination (Charles et al., 2000).”
BackgroundPerturbed Myelination Process of Premyelinating Oligodendrocyte in Niemann-PickType C Mouse
Takikita, S., Fukuda, T., Mohri, I., Yagi, T., & Suzuki, K. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.6.660 · Cited by 81
“PSA-NCAM has a negative regulation on myelination and downregulation of its expression in axons allows the axons to myelinate (16).”
BackgroundDiversity of oligodendrocytes and their progenitors
Dimou, L., & Simons, M. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.09.015 · Cited by 93
The Lysosomal Sialic Acid Transporter Sialin Is Required for Normal CNS Myelination
Prolo, L. M., Vogel, H., & Reimer, R. J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3005-09.2009 · Cited by 75
“PSA-NCAM is downregulated at the onset of myelination, and its overexpression in vitro leads to a delay in oligodendrocyte maturation and myelin formation (Charles et al., 2000; Franceschini et al., 2004; Fewou et al., 2007).”
LINGO-1 antagonists as therapy for multiple sclerosis:in vitroandin vivoevidence
Rudick, R. A., Mi, S., & Sandrock, A. W. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.10.1561 · Cited by 87
“2) promote oligodendrocyte differentiation [55] , whereas LINGO-1, polysialic acidcontaining neural cell adhesion molecules, and activated Notch receptors negatively regulate oligodendrocyte differentiation and myelination [28,56,57] .”
BackgroundBakhti, M., Snaidero, N., Schneider, D., Aggarwal, S., Möbius, W., Janshoff, A., Eckhardt, M., Nave, K.-A., & Simons, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220104110 · Cited by 75
“For example, loss of polysialic acid from neural cell adhesion molecule (NCAM) in neurons initiates myelination (49, 50).”
BackgroundNataf, S., Anginot, A., Vuaillat, C., Malaval, L., Fodil, N., Chereul, E., Langlois, J., Dumontel, C., Cavillon, G., Confavreux, C., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62251-1 · Cited by 79
Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies
Tognatta, R., & Miller, R. H. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.026 · Cited by 73
“, 2002) and removal of PSA by endosialidases has been shown to enhance remyelination (Charles et al., 2000).”
BackgroundGDE2-Dependent Activation of Canonical Wnt Signaling in Neurons Regulates Oligodendrocyte Maturation
Choi, B.-R., Cave, C., Na, C. H., & Sockanathan, S. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107540 · Cited by 72
“Neuronal GDE2 and OL Maturation Known factors in neurons that regulate OL development include contact-dependent signals between axons and oligodendroglia, axon caliber, and neuronal activity (Charles et al., 2000; Gibson et al., 2014; Lee et al., 2012).”
In vitro modeling of central nervous system myelination and remyelination
Jarjour, A. A., Zhang, H., Bauer, N., ffrench‐Constant, C., & Williams, A. (2012) · Glia · doi:10.1002/glia.21231 · Cited by 69
“…factors, (Allamargot et al., 2001; Ishibashi et al., 2006; Jean et al., 2002; Piaton et al., 2011), contact-mediated signals (Camara et al., 2009; Charles et al., 2000; Zonta et al., 2008), and electrical activity (Demerens et al., 1996; Stevens et al., 2002) which all require the presence of…”
BackgroundIn Vitro and In Vivo Pharmacological Models to Assess Demyelination and Remyelination
Merrill, J. E. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.145 · Cited by 69
“Myelination in these cultures systems is quantitated by counting of MBP-stained cells or the number of internodes/myelin segments, by toluidine blue staining (Wilson), and by validation of compact myelin using EM (Charles et al, 2000; Demerens et al, 1996; Stevens et al, 2002).”
MethodThe Quest for Remyelination: A New Role for Neurotrophins and Their Receptors
Rosenberg, S., Ng, B. K., & Chan, J. R. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00035.x · Cited by 78
“Although none of the axonal signals downstream of TrkA have currently been identified, potential candidates include the neuregulins (32, 38), LINGO-1 (31), and various cell adhesion molecules such as polysialic acid neural cell adhesion molecule (PSA-NCAM) (13), and L1 (41).”
BackgroundA mouse model for testing remyelinating therapies
Bai, C. B., Sun, S., Roholt, A., Benson, E., Edberg, D., Medicetty, S., Dutta, R., Kidd, G., Macklin, W. B., & Trapp, B. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.06.033 · Cited by 65
“For example, surface protein polysialylated-neural cell adhesion molecule (PSA-NCAM), which is expressed at high levels in chronic MS Lesions (Charles et al., 2002, 2000), may inhibit myelin sheet formation during remyelination.”
BackgroundRemyelinating Pharmacotherapies in Multiple Sclerosis
Bove, R. M., & Green, A. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0577-0 · Cited by 69
“Many of the signaling pathways initially identified were axonally derived (LINGO-1 [9, 10], PSA-NCAM [11], Notch signaling [13–16], retinoic acid receptor retinoid X receptor (RXR-γ) pathway [19]), supporting the perception that axons regulate myelination.”
BackgroundInfluentialPluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects
Singh, R. K., Cuzzani, O., Binette, F., Sternberg, H., West, M. D., & Nasonkin, I. O. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9802-4 · Cited by 70
“sociated with axonal myelination (myelination increases, while polysialylation decreases with axonal/neuronal maturation) [243].”
Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination
Bernard, F., Moreau‐Fauvarque, C., Heitz‐Marchaland, C., Zagar, Y., Dumas, L., Fouquet, S., Lee, X., Shao, Z., Mi, S., & Chédotal, A. (2012) · Glia · doi:10.1002/glia.22378 · Cited by 63
“…2010; Simons and Trotter, 2007) and multiple secreted and transmembrane factors, such as poly-sialylated neural cell adhesion molecule (PSA-NCAM; Charles et al., 2000), neuregulin (Brinkmann et al., It was recently shown that oligodendrocyte development is also influenced by axon guidance…”
BackgroundFerrer, I. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.07.004 · Cited by 62
“2, potassium-gated channels; LB, Lewy body; LBD, Lewy body disease; LINGO-1, leucine-rich repeat and Ig domain containing 1; LRRK2, leucine-rich repeat kinase 2; MAG, myelin-associated glycoprotein; MAP, microtubule-associated protein; MAPK/ERK, mitogen-activated protein kinase/extracellular signal-regulated kinase; M…”
Background
Metadata
- Authors
- Charles, P., Hernandez, M. P., Stankoff, B., Aigrot, M. S., Colin, C., Rougon, G., Zalc, B., & Lubetzki, C.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-06-06
- Volume
- 97
- Issue
- 13
- Pages
- 7585-7590
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC16589
- OpenAlex
- W2141426770
- Cited by
- 306
- References
- 28
- Citations by year
- 2026: 12 · 2025: 4 · 2024: 9 · 2023: 7 · 2022: 5 · 2021: 2 · 2020: 11 · 2019: 12 · 2018: 13 · 2017: 16 · 2016: 9 · 2015: 17 · 2014: 16 · 2013: 25 · 2012: 14
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL AMU (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Keywords
- PSA-NCAM, myelination, oligodendrocytes, axons, optic nerve, tetrodotoxin, central nervous system development
- MeSH terms
- Animals, Cells, Cultured, Central Nervous System, Membrane Potentials, Myelin Sheath, Neurons, Down-Regulation, Neural Cell Adhesion Molecules, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.